Skip to main content
. 2012 Aug;22(4):246–254. doi: 10.1089/nat.2012.0345

FIG. 1.

FIG. 1.

Pulmonary safety testing of oligonucleotides. The incorporation of clinical tests during the pre-clinical and clinical stage of development of inhaled oligonucleotides should establish a clear correlation with histopathology, assess the sensitivity of the tests, and ultimately confirm their utility for the detection of lung lesions in human.